siRNA treatment reduces triglycerides in patients with uncommon ailment

.ANALYSIS HIGHLIGHT.19 September 2024.

Plozasiran lowered triglyceride degrees by 80% and lowered the threat of pancreatitis in individuals with chronic chylomicronemia, with or even without a genetic prognosis.